Occult papillary thyroid carcinoma presenting as incidental cervical lymph node metastasis

case report

Authors

DOI:

https://doi.org/10.61695/rcs.v4i1.108

Keywords:

Thyroid cancer, Papillary thyroid carcinoma, Lymph node metastasis, Immunohistochemistry

Abstract

Introduction: Papillary thyroid microcarcinoma rarely presents as occult cervical metastasis in the absence of clinical evidence of thyroid cancer, which makes diagnosis difficult and delays treatment. Objective: To report a case of occult cervical lymph node metastasis from papillary thyroid microcarcinoma. Case report: A 52-year-old female physician with a history of Hashimoto’s thyroiditis and hypothyroidism, on levothyroxine therapy, presented without evidence of primary thyroid cancer on ultrasound examination (US). During magnetic resonance imaging performed for investigation of cervical disc herniation, an infraclavicular metastatic cervical lymph node was identified. The patient underwent lymph node biopsy; frozen section and initial immunohistochemical analysis suggested metastatic adenocarcinoma primarily originating from the female genital tract or lung. Further investigation included gynecological evaluation, which was unremarkable, and thyroid ultrasound showing decreased echogenicity and a 0.9 × 0.6 cm calcification. A review of the immunohistochemical analysis revealed papillary thyroid microcarcinoma. The patient underwent total thyroidectomy, cervical neck dissection, TSH suppression, and radioactive iodine therapy. After nine years of follow-up, she remains free of metastatic disease. Conclusion: The authors highlight the incidental diagnosis of occult lymph node metastasis from papillary thyroid carcinoma, supporting the hypothesis that this tumor type should not be considered low risk solely based on tumor size, as it may present with asymptomatic and occult lymph node metastasis.

Downloads

Download data is not yet available.

Author Biographies

Katia Torres Batista, Centro Universitário Unieuro

Docente do curso de Medicina, Centro Universitário Unieuro, Brasília, Distrito Federal, Brasil

Arthur Dutra Bomfim, Centro Universitário Unieuro

Discente do curso de Medicina, Centro Universitário Unieuro, Brasília, Distrito Federal, Brasil.

Jamille Goudard da Silveira Braide, Centro Universitário Unieuro

Discente do curso de Medicina, Centro Universitário Unieuro, Brasília, Distrito Federal, Brasil.

Judi Carla Rocha, Centro Universitário Unieuro

Discente do curso de Medicina, Centro Universitário Unieuro, Brasília, Distrito Federal, Brasil.

Lenise Maria Spadoni-Pacheco, Centro Universitário Unieuro

Docente do curso de Medicina, Centro Universitário Unieuro, Brasília, Distrito Federal, Brasil.

References

Ito Y, Hirokawa M, Fukushima M, Inoue H, Yabuta T, Uruno T, et al. Occult papillary thyroid carcinoma: diagnostic and clinical implications in the era of routine ultrasonography. World J Surg. 2008;32(9):1955-60. doi: 10.1007/s00268-008-9614-9. PMID: 18594906.

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133. doi: 10.1089/thy.2015.0020.

Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019;30(12):1856-83. doi: 10.1093/annonc/mdz400.

Lee YC, Na SY, Park GC, Han JH, Kim SW, Eun YG. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study. Surgery. 2017 Feb;161(2):465-471. doi: 10.1016/j.surg.2016.07.031.

Boucek J, Kastner J, Skrivan J, Grosso E, Gibelli B, Giugliano G, et al. Occult thyroid carcinoma. Acta Otorhinolaryngol Ital. 2009;29(6):296-304. PMID: 20463833;

Liu H, Lv L, Yang K. Occult thyroid carcinoma: a rare case report and review of literature. Int J Clin Exp Pathol. 2014;7(8):5210-4. PMID: 25197399.

Taniuchi M, Kawata R, Terada T, Higashino M, Aihara T, Jinnin T. Central node dissection from the perspective of lateral neck node metastasis in papillary thyroid carcinoma. Auris Nasus Larynx. 2024;51(2):266-70. doi: 10.1016/j.anl.2023.10.003.

World Health Organization. Internacional Agency for Research on Cancer. Endocrine and Neuroendocrine Tumours: WHO Classification of Tumours. France: 5th ed; 2025. https://www.iarc.who.int/news-events/publication-ofthe-who-classification-of-tumours-5th-edition-volume-10-endocrine-and-neuroendocrine-tumours/

Jin L, Zhu K, Xu C, Lu J, Huang L. Incidence and risk factors for occult lesions in low-risk papillary thyroid microcarcinoma patients with tumor characteristics appropriate for thermal ablation: a retrospective study. Medicine (Baltimore). 2023;102(38):e34938. doi: 10.1097/MD.0000000000034938.

Russ G, Leboulleux S, Leenhardt L, Hegedüs L. Thyroid incidentalomas: epidemiology, risk stratification with ultrasound and workup. Eur Thyroid J. 2014;3(3):154-63. doi: 10.1159/000365289.

Huang H, Xu S, Ni S, Wang X, Liu S. A nomogram for predicting lateral lymph node metastasis in cN0 unifocal papillary thyroid microcarcinoma. BMC Cancer. 2023;23(1):718. doi: 10.1186/s12885-023-11219-0.

Cai HZ, Zhuge LD, Huang ZH, Shi P, Wang SX, Zhao BH, et al. Risk factors of occult lymph node metastasis of levels Ⅲ and Ⅳ in papillary thyroid carcinoma. Zhonghua Zhong Liu Za Zhi. 2023;45(8):692-696. doi: 10.3760/cma.j.cn112152-20221202-00804.

American Thyroid Association. ATA’s Annual Meeting Oct 19 - 23, 2022 Palais des Congrès de Montréal Montréal, Quebec, Canada 2022. https://www.thyroid.org/91st-annual-meeting-ata/

Haddad RI, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy NL, et al. Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(8):925-51. doi: 10.6004/jnccn.2022.0040.

Gábor L. Kovács, Gábor G, István S. Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid, 2005;15:152-7. https://doi.org/10.1089/thy.2005.15.152

Afolabi AO, Alegbeleye BJ, Olagunju N. Occult thyroid carcinoma: a tertiary hospital experience in Ibadan, Nigeria. Iberoam J Med. 2021;3(3): 212-20. https://dx.doi.org/10.5281/zenodo.4771174.

Kim HI. Prognostic significance of Hashimoto thyroiditis in papillary thyroid carcinoma: systematic review and meta-analysis. Front Endocrinol. 2022;13:935723.

Sun H. Predictors of occult lateral lymph node metastasis in papillary thyroid microcarcinoma: updated metaanalysis. Head Neck. 2025;47(3):622-33.

Rossi ED, Pantanowitz L, Faquin WC. The role of molecular testing for thyroid nodules in 2024. Cancer Cytopathol. 2024;132(1):5-18.

Published

2026-05-28

How to Cite

Batista, K. T., Bomfim, A. D., Braide, J. G. da S., Rocha, J. C., & Spadoni-Pacheco, L. M. (2026). Occult papillary thyroid carcinoma presenting as incidental cervical lymph node metastasis: case report. Revista Ciências Da Saúde Ceuma, 4(1), 1–10. https://doi.org/10.61695/rcs.v4i1.108

Issue

Section

Article